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ABSTRACT  
Objective: To deliver bioadhesive buccal films of artemether (ART) with ability to adhere, hydrate and release drug across the buccal 
membrane. Methods: Buccal films prepared by film casting using carrageenan (CAR) and Prosopis africana (PRO) were characterized by size, 
zeta potential, texture, water content, morphology, thermal and interaction studies, in vitro and in vivo antiplasmodial activity in mice. Results: 
Films were stable with sizes (2442 and 835 nm), water content (21 and 15 %), bioadhesivity (24 and 9.4 %) and film thickness (0.18 and 0.28 
mm) for CARART and PROART respectively. Enthalpy of CARART, PROART and ART were 76, 22 and 88 J/g where as parasitaemia reduc tion of 
67 and 76 % were observed for CARART and PROART respectively. Conclusion: Though CARART had better water content and bioadhesivity 
necessary for film hydration at buccal membrane, PROART eventually had superior buccal performance perhaps due to its film th ickness and 
amorphous nanoparticle subdivision.  
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1. INTRODUCTION  
There has been a paradigm shift from conventional 
drug delivery systems (injections and orals) to alternative 
systems based on versatile novel drug delivery systems 
(NDDS) 1-4. NDDS are capable of delivering drugs through 
mainly non-invasive routes with the aim to improve use 
convenience and compliance5. These systems exploit the 
mucosal surfaces of skin, nose and oral cavities while 
delivering drugs through different carrier systems6. By 
implication, delivery systems such as topicals (gels, films, 
patches, creams etc), aerosols and other transdermal DDS 
not limited to the oral cavity (sublingual, oesophageal, and 
buccal systems) apply. Buccal delivery systems (BDS) may 
include disks, tablets, patches, liquids and semi-solids7-10 but 
among all, films and/or patches have shown greater 
preference8-11. These systems generally need to be bio- 
and/or muco-adhesive to be able to withstand some obvious 
stresses due to their application sites, to be able to provide 
both local and/or systemic effects. For instance, due to the 
flushing action of saliva and/or food ingestion, BDS may 
suffer from frequent dosing, non-uniform absorption as well 
as dislodgement by the tongue10, 12. Drug ionization could 
also occur for ionizable drugs due to pH of 
microenvironment thereby making the route impracticable 
for drugs with low pKa values since pH of the saliva is 6.5-
6.913, 14. Therefore, to increase BDS residence contact time on 
mucosal membranes, hydrogel polymers (having numerous 
hydrogen bonding groups) could be used to provide 
bioadhesivity and flexibility11, 14. This would predispose BDS 
to proffer numerous advantages such as to bypass liver 
metabolism, avoid gastric irritation and enzymatic 
degradation in the gastrointestinal tract (GIT), provide local 
specificity and above all, improve use convenience and 
compliance15-17. Hence different local conditions of the oral 
cavity could easily be treated with BDS including oral ulcers, 
oral infections, dental caries, periodontitis, gingivitis etc14, as 
well as systemic administration of macromolecular agents 
such as peptides, proteins, and polysaccharides4, 11. 
 Prosopis africana (PRO) polymer is obtained from 
the tropical plant Prosopis africana. Similar to k-carragenan 
(CAR), PRO is a generally regarded as safe (GRAS) polymer 
for different uses including extended release polymer18, 
bio/muco-adhesive systems19, 20; solubility enhancer21, 
plasticizer21, binder for tablets22, film/patches21, 23, food 
supplement24-26, antimicrobial27, and water treatment28 etc. 
Prosopis gum is a natural polysaccharide consisting chiefly of 
glucose, fructose, galactose and xylose as the 
monosaccharide units, as determined by thin layer 
chromatography and complete acid hydrolysis analysis19, 29. 
The gum is made up of highly branched polysaccharides with 
chain structure formed when monosaccharides condense 
with the elimination of water molecule(s)19. The structural 
components of its rich amino acid constituents have been 
implicated in solubility enhancement properties through 
abundant hydrogen bonding groups21. It is a well-known 
biodegradable and biocompatible bioadhesive agent due to 
its anionic nature which aids more effective mucosal and/or 
tissue binding18-20. Additionally, it is a sought-after food 
condiment for the Nigerian people due to its low toxicity. In 
the light of its bioadhesivity, low toxicity and cheap 
availability, it can be proposed as a delivery system for 
developing effective buccal adhesive films for treatment of 
some tropical disease such as malaria.  
The antimalarial drug, artemether (ART) is a fast 
acting schizonticidal drug and the most effective of the 
artemissinin-combination therapies (ACT) for first-line 
treatment of malaria30. The challenge of drug resistance by 
Plasmodium parasite makes a short acting drug such as ART 
not to be useful as a monotherapyas conventionally 
obtainable, example in the capsule form (80-160 mg daily for 
5 days)21. Instead, the fast-acting derivatives of artemissinin 
(artemether, dihydroartemisinin, arteether and artesunate) 
are combined with long acting antimalarials (lumenfantrine, 
amodiaquine, sulfadoxin-pyrimethamine, mefloquine, 
piperaquine) as ACTs, to deal with fast resolution of clinical 
symptoms as well as recrudescence31. Among all ACTs, 
artemether-lumenfantrine is the most widely used in 
different fixed oral (tablets) combinations (80/480, 40/240 
and 20/120 mg) for treatment of uncomplicated falciparum 
malaria including multi-drug resistant ones21, 31. The large 
oral doses have attendant associated side effects (especially 
neurotoxicity) following twice daily dosing and rapid but 
incomplete absorption after oral administration with peak 
plasma concentrations reached about 2 h in addition to 
metabolism in the liver to the demethylated derivative, 
dihydroartemisinin (DHA)21. More so, it is rapidly eliminated 
with oral bioavailability after intramuscular injection approx. 
43%. Therefore, ART administration via the oral mucosa 
(buccal and sublingual) seems attractive due to its short 
action which could resolve its hepatic first-pass metabolism 
and degradation in the gastrointestinal tract, GIT14, 32. This is 
hoped to exploit the rich blood supply (20.3 mL/min/100 g 
tissue) available in the oral mucosa, the high surface area 
(50.2 cm2) as well as thin membrane (low thickness) 500–
600 μm therein, to generally increase ART uptake14, 33. 
In the light of the above, we report here the 
development of solvent cast films for buccal delivery of 
artemether (ART). These drug films were produced with k-
Carrageenan (CAR) and Prosopis africana(PRO) as hydrogel 
polymers with the aid of propylene glycol (plasticizer), 
saccharine sodium (sweetner) and peppermint oil 
(flavourant); following optimizations of concentration 
(plasticizer, polymer, sweetner and flavor), drying time, 
temperature and functional properties of the final films. The 
resultant drug films (CARART and PROART) were 
characterized by thickness, drug content, folding endurance, 
morphology, weight variation, viscosity, degree of 
crystallinity and compatibility, in vitro drug release, ex vivo 
bioadhesivity and in vivo growth inhibition of plasmodium in 
malariogenic mice. To understand the particle make-up, 
carefully measured film size (2 cm2) was allowed to swell for 
8 h in milliQ-water (5 ml) of pH 6.8 and the aqueous 
dispersion was checked for size (Z-ave), polydispersity index 
and zeta potential. All these were done to provide proof as to 
hope for effective BDS of ART which could improve use 
convenience and compliance to reduce development of 
resistance as well as an alternative low dose regimen to oral 
large-dosed tablets. 
2. MATERIALS AND METHODS  
2.1. Materials 
 Artemether was a gift from Ipca Laboratories Ltd. 
India. Other ingredients include k-carrageenan and absolute 
ethanol, (Sigma Aldrich, Germany), propylene glycol, sodium 
saccharine andpeppermint oil (Merck, Germany). All other 
reagents and solvents were analytical grade and were used 
as procured.  
2.2. Preparation of Prosopis polymer 
 Prosopis seed was procured from Orba market, 
Udenu Local Government Area of Enugu State, Nigeria. 
Prosopis africana peel powder (PAPP) was prepared 
according to earlier methods18, 28, 34, with slight 
modifications. Briefly, Prosopis seeds were boiled overnight. 
After the inner fermentable seed (soup flavorant in Nigeria) 
was separated from the peels, there was further separation 
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of the peel into two parts: 1) fleshy white mesocarp (gum 
containing portion) and, 2) hard pericarp (outermost part). 
The white mesocarp (gum) was washed (thrice) with 
deionized water, sun-dried to constant weight and ground 
into powder using laboratory grinding machine. The powder 
was sieved with a laboratory sieve of known mesh size to 
obtain fine powders used for this study. 
2.3. Formulation of films 
 Prior to final preparations, all parameters including 
concentration (polymer, drug, plasticizer, sweetner and 
flavorant), stirring time and drying temperature were 
optimized. To determine the optimal drying time, equal 
amount of dispersion was poured into Petri dishes (diameter 
3.4 cm2) and weighed every 24 h up to 72 h until a constant 
weight was achieved. An impermeable backing 
membrane/layer was prepared from ethanol (E), 
ethylcellulose (EC) and soy bean oil (SBO) to represent 4 and 
10 %w/v respectively of SBO and EC in absolute E. The 
mixture was stirred until homogeneous solution was 
obtained. This solution (10 ml) was poured into Petri dish 
(3.4 cm) and dried in the oven at 30 °C for 3 h. 
  Aqueous solution of polymers (k-carragenaan (CAR) 
and Prosopis polymer (PRO)) were prepared by separately 
adding 1 g of CAR or PRO to 25 ml of distilled water and 
stirring for 5 min. Some 10 mg of saccharine sodium 
(sweetner) was added to solution and stirred for 5 min, 
before addition of propylene glycol (10 ml) as plasticizer and 
stirring for another 1 min35. This was followed by the 
addition of 1 ml of peppermint oil (flavourant) and final 
stirring for further 1 min to give solution A. For the blank 
films (without drug), the resultant solution A was cast into 
Petri dishes (diameter 3.4 cm) containing the dried backing 
layers and covered with an inverted funnel for gradual 
drying at room temperature. For the drug-containing films, 
optimized concentration of 500 mg of artemether (ART) was 
added into 5 ml of absolute ethanol and stirred for 5 min to 
give solution B. Solution A was separately added into 
solutions B and mixtures were stirred for 10 min before 
casting as earlier described. Triplicate formulations were 
made for each batch. After drying at room temperature, the 
films were stored in desiccators until used. Artemether films 
formulated with carrageenan were coded as CARART while 
those formulated with Prosopis africana were referred to as 
PROART.  
2.4. Physical evaluation of hydrogels 
Prior to casting, the hydrogel formulations were 
physically examined for color, homogeneity, and consistency. 
The pH was also re-evaluated (before each use) to make sure 
that it was stable within the salivary pH of 6.5-6.9.  
2.5.  Morphology and texture analysis  
 The morphology of the film samples was analyzed 
through scanning electron microscopy (SEM). The dry films 
were gold coated to about 5 µm thickness using a coater unit 
under a high vacuum. SEM analysis of films (PROART and 
CARART) was performed on a Philips XL-30M scanning 
electron microscope instrument. 
2.6.  Microenvironment pH and particle 
characterization  
  The microenvironment pH of carefully measured 
film sizes (2 cm2) were determined to evaluate possible oral 
mucosal irritation. The films were allowed to swell for 8 h in 
milliQ-water of pH 6.8 contained in small beakers. The pH of 
the aqueous dispersion was determined using a pH meter 
(L1 127 Elico, India). Triplicate measurements were done 
per batch of formulation.  
 The mean diameter (Z-ave) and polydispersity index of 
the above aqueous dispersions obtained from CARART and 
PROART films were measured after appropriate dilutions 
using a Zetasizer Nano-ZS (Malvern Instruments, Worcester, 
UK) equipped with a 10 mW He–Ne laser employing the 
wavelength of 633 nm and a backscattering angle of 173 ° at 
25 °C. All samples were diluted with sufficient milliQ-water 
to obtain a suitable scattering intensity, before photon 
correlation spectroscopic (PCS) analysis, and were then 
placed in a 10 mm diameter cell. Particle size analysis was 
performed using Mie theory. 
  The zeta potentials of the drug films were 
determined via electrophoretic mobility measurements 
using a Zetasizer Nano-ZS (Malvern Instruments, 
Worceshtire, UK). The zeta potential was calculated applying 
the Helmholtz–Smoluchowski equation (n = 3). 
2.7. Technological evaluation of the films 
The thickness of the film was measured with 
micrometer screw gauge (Mitutoyo, Kawasaki Japan). The 
measurement was taken at five different areas of the film; 
four around the edges and one in the center. The mean and 
standard deviation of the five measurements was calculated 
for each film. For weight variation, ten films from each of 
CARART and PROART batches were individually weighed. 
Variations in weight were determined after triplicate 
determination. The Folding endurance (FE) of the 
formulated films were determined by repeatedly folding the 
films of uniform cross-sectional area (4x4 cm2) and 
thickness, at the same place until it broke. The number of 
times each film was folded at the same place without 
breaking gave the value of FE. Triplicate determinations 
were done for validity of statistical result. 
2.8. Bioadhesive evaluation of the films 
The bioadhesive property of the formulated films were 
determined using a texture analyzer (TA.XT2, Stable Micro 
System, UK) and fresh chicken pouch as a model tissue as 
previously described36 with slight modification. The 
calculated work of adhesion was used as a measure of the 
bioadhesive property of the films. 
2.9. Differential scanning calorimeter (DSC) 
DSC experiments (TA Instrument, USA) were 
performed to detect the phase transition of the pure 
compounds and their mixtures as well as investigate any 
possible interaction between the initial compounds used to 
prepare the films. To investigate the transition of drug 
molecule from crystalline to amorphous form during the 
formulation process, sufficient quantity of PROART and 
CARART films enough to contain at least 3–5 mg of ART was 
weighed in aluminum pans, heated from 25 to 150 oC at 10 
C/min under constant flushing with nitrogen (10 ml/min). 
The DSC parameters, such as temperature onset, maximum 
peak, and enthalpy were generated. 
2.10. Fourier transform infrared spectroscopy(FT-IR)  
FT-IR study was carried out using BIO-RAD FT-IR 3000 
(BIORADCompany, USA). The FT-IR spectra of PROART and 
CARART buccal films, ART, PRO and CAR polymers were 
obtained using KBr discs in the region of 4000–500 cm-1. 
2.11. Thermogravimetic analysis (TGA) 
TGA was used to measure the water content within the film. 
Samples weighing between 3 and 10 mg were packed into 
aluminum pan and placed in a tarred balance of a high-
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resolution TG 2950 instrument (Crawley, UK). The TGA was 
programmed to heat the sample from 25 to 150 oC at the rate 
of 10 oC/min. The weight loss was noted and used to 
calculate the water content of the films.  
  2.12. Drug content analysis 
Accurately weighed 100 mg of drug film (CARART 
and/or PROART) was transferred to a 100 ml volumetric 
flask and dissolved with 5 ml of ethanol. To it, 25 ml of 1N 
HCl was added and heated using thermo-regulated water 
bath for 30 min at temperature of 80±2 oC, slightly modified 
according to an earlier method37. The solution was allowed 
to cool at room temperature, filtered and the volume was 
made up to 100 ml mark with deionized water and/or 
simulated salivary fluid, SSF (pH 6.5). This was scanned in a 
UV/VIS spectrophotometer (Spectrumlab 752s, UK) at 254 
nm and the amount of drug was calculated reference to a 
Beer’s plot.  
2.13. Dissolution rate studies and drug release 
kinetics 
Drug dissolution studies were determined using 
magnetic stirrer method. Some 50 ml of two different 
dissolution media (deionized water and SSF, pH 6.5) 
contained in beakers were placed on magnetic stirrer hot 
plate at 37 oC with stirring speed of 100 rpm. A volume of 5 
ml was withdrawn at initial 30 min interval then at hourly 
interval for 12 h while replacing each withdrawal with 5ml of 
fresh media. However, to each 5ml withdrawn sample at 
different time intervals, 0.5 ml of ethanol and 2.5 ml of 1N 
HCl were added and heated for 25 min in a water bath at 
80±2 oC, cooled, filtered and diluted to 10 ml with the 
medium before UV/VIS measurement (Spectrumlab 752s, 
UK) at 254 nm. 
Different release models37 were applied to study the kinetics 
and mechanisms of ART release from mucoadhesive films 
including zero order, first order, Higuchi and Korsmeyer-
Peppas models. First order assessed log cumulative of % 
drug remaining versus time whereas zero order was done by 
fitting cumulative % drug release versus time38. The 
cumulative % drug release versus square root of time 
described Higuchi model, whereas Ritger-Peppas and 
Korsmeyer-Peppas models assessed both Fickian and non-
Fickian release of drug from swelling as well as non-swelling 
systems by Log (Mt /M∝) = Log k + n Log t. The best fit 
model depended on the linearity of the plots as represented 
by the R2 values37. 
2.14. Ex vivo buccoadhesivity of films on bovine 
buccal membrane 
Bovine buccal mucosa was collected from freshly 
slaughtered cow from Ogige market abattoir, Nsukka 
(Nigeria) and frozen until used. The mucin lining of the 
buccal membrane was gently scraped off with spatula 
leaving a thin membrane which was spread on Teflon block 
and wrapped with aluminum foil before storing in the 
freezer. Prior to use, it was thawed in saline solution at 
ambient temperature.  
The biological membrane was fixed on a non-absorbable 
surface then pinned with dissecting pins to prevent the 
tissue from slipping off. The film was attached to the ring of 
the Du Nouy tensiometer with cyanoacrylate adhesive and 
lowered to make contact (5 min) with the tissue membrane 
on the platform39. The ring with the film was gradually raised 
at the rate of 1 mm/min. The force (g) was taken at equal 
intervals until the film was completely detached from the 
tissue membrane. Film contact time with the intestine was 5 
min in each determination and a curve was traced between 
contact time (min) and force (g) whereby the work of 
adhesion (g/cm) was equal to the area under the curve. 
Triplicate determinations were taken for each film batch. 
2.15. In vivo schizontocidal activity  
The animal experimental protocols were in 
accordance with the guidelines for conducting animal 
experiments stipulated by our Institution’s Animal Ethics 
Committee40 and in compliance with the Federation of 
European Laboratory Animal Science Association and the 
European Community Council Directive of November 24, 
1986 (86/609/EEC). Briefly, the mice were divided into four 
groups of five mice each. 
Evaluation of the curative effect of formulated films 
against established plasmodium infection was carried out37. 
On the day 0 of the test, percentage parasitemia and red 
blood cell count of the donor mice was determined by a 
Giemsa-stained thin blood smear of the donor mice and 
improved Neubauer counting chamber respectively. Blood of 
the donor mice was collected by cardiac puncture and 
diluted with physiological saline (normal saline) to 108 
parasitized erythrocytes per ml (i. e. 0.2 ml of 108 parasitized 
erythrocyte/ml),which was injected intra-peritoneally into 
each of the experimental mice in Fig. 1 (image A, B). Thirty 
mice were all inoculated with chloroquine-sensitive strain of 
Plasmodium berghei berghei (NK 65) and left untreated until 
the fourth day (D4) post inoculation. The mice were weighed 
and randomized into six groups of five mice each. Post 
inoculation (day 4), Group A (negative control) was 
administered with 1 ml/kg of distilled water, group B 
(positive control) received 5 mg/kg body weight equivalent 
to 12..5 mg of ART oral tablet dispersed in 1 ml of distilled 
water. Groups C and D received uniform doses of ART (5 mg) 
contained in drug film of CARART (11.4 mg) and PROART 
(12.4 mg) which were carefully stocked to the palates of the 
mice (image C).  On day-7 (D7), each mouse was tail-bled 
(image D) and a thin blood film was made on a microscope 
slide. The films were stained with 10% Giemsa solution and 
examined microscopically to monitor the parasitaemia level. 
The antimalarial activity was determined by the equation:                
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C: 
Placement of drug film into the buccal cavity D: Collection of blood after treatment 
Fig. 1: Preparation and treatment of malariogenic mice 
 
2.16. Statistical analysis 
 All the data generated were expressed as mean ± 
standard deviation. For group comparisons, one-way ANOVA 
with duplication was applied. Statistical significance was 
determined using student t-test, with P<0.05 considered to 
be statistically significant.  
3. RESULTS 
3.1. Physical evaluation of hydrogels  
To increase residence, contact time of the films on mucosal 
membranes, hydrogel polymers (PRO and CAR), having 
numerous hydrogen bonding groups were used to provide 
bioadhesivity and flexibility11, 14. The PROART hydrogel 
formulated was homogenous, partially transparent and 
fairly viscous, while the PROART film was moderately 
transparent. The CARART hydrogel was homogenous, 
transparent and less viscous than PROART, while the 
CARART film was very transparent. CARART films were 
therefore lighter than PROART films as well as had more 
uniform measurements. Hydrogel particles were spherical 
but not so in dry films. 
3.2.  Morphology and texture analysis 
Scanning electron microscopic (SEM) analysis was adopted 
to investigate the surface characteristics and internal 
structure of the formulated artemether-loaded films 
(CARART and PROART). Single particles of the polymers CAR 
(A-C), PRO (J-L) and ART (M-O) in (Fig. 2) appeared more 
cuboid while ART-films CARART (D-F) and PROART (G-I) 
were of different shapes. The shape of drug carriers have 
been reported to be dependent on the purity of the carriers 
used41 and particles prepared from highly pure 
lipids/carriers are usually more cuboid in nature42, 21. PRO 
and CAR have high polydispersity indices (>0.8) in Table 1, 
showing they are chemically polydispersed as well as highly 
pure. Even though expected that only spherical particles 
would be present in all formulations, it should also be 
realized that the polymorphic nature of the carriers (data in 
brief) could determine the shape of particles. So that 
particles which existed in the stable β-modification could 
assume anisometric shapes, whereas those that existed in 
the metastable α-polymorphic forms could appear spherical 
in nature43, 44. This agreed with literature as the particle 
shape making up the drug films could be spherical45 and/or 
non-spherical21. 
SEM images of the film surface and internal matrix are 
shown in Fig. 2 (A to O).  The blank polymer films of CAR 
(images A-C) and PRO (images J-L) had uniform smooth 
appearance compared to the CARART (images D-F) and 
PROART (images G-I) films which in turn appeared uniform 
but slightly rough. However, with closer look into the 
internal structure, there appeared to be a higher, though 
irregular distribution of the ART within the film matrices 
(CARART) and (PROART). The internal structure of the 
PROART film (images G-I) showed more uniform 
distribution of irregularly shaped ART within the film matrix 
compared to CARART films (D-F) which had needle-like 
and/or rice-like particle clusters. This suggests that PROART 
film may have higher capacity for drug loading and 
retention, with fewer tendencies for drug expulsion to the 
film surface, than the CARART films. However, subsequent 
results would provide further proof on this. 
 
Table 1: Properties of formulation 
Batch Z-Ave 
(d. 
nm) 
PDI ZP 
(mV) 
Thickness 
(mm) ± SD 
Bioadhesive 
activity 
(g/mm) 
Equilibrium 
Water 
content  
(%) 
Ex-Vivo 
Bucco 
Adhes. 
Strength± 
SD 
Melting 
peak 
(°C) 
Enthalpy 
(J/g) 
ART - - - - - 1.70 ± 0.01 - 86.96 87.51 
CARART 2442.0 1.00 -64.4 0.18±0.02 23.76 ± 1.12 21.40 ± 0.08 38±1.01 207.05 76.02 
PROART 853.2 0.62 -10 0.28±0.04 9.38 ± 0.58 15.02 ± 0.67 30±1.21 186.25 21.63 
CAR 568.50 0.80 -50.5 0.08±0.01 19.24 ± 0.11 18.00 ± 0.06 25±0.90 242.05 -3.16 
PRO 798.9 0.92 -9.6 0.19±0.01 17.24 ± 0.81 10.14 ± 0.06 21±0.78 312.55 -0.79 
Legends: Because the films had low water contents compared to pro-hydrogel state, the term equilibrium water content has 
been chosen. 
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A B C 
D  E F 
G H I 
J K L 
M N O 
Fig. 2: Morphology and internal structure of drug films and polymers. 
Legends: Surface, internal structure and enlarged internal structure of k-carrageenan, CAR (A-C); drug film, CARART (D-F); 
drug film, PROART (G-I); Prosopis africana polymer, PRO (J-L) and drug, ART (M-O) respectively. 
 
3.3. Microenvironment pH and particle 
characterization 
The microenvironment of the films had the required pH 
within the range for saliva (6.5-6.9). This shows that the 
formulation would likely not irritate the buccal mucosa. 
Particle size characterization of the pure polymers (CAR and 
PRO) were 568.5 and 798.9 nm respectively whereas their 
drug films (CARART and PROART) were 2442 and 853 nm 
respectively (Table 1). This implies that PROART films had 
better particle subdivision in the nanometer region than the 
CARART. This agrees with the observation in morphology 
and internal structure. 
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3.4. Technological evaluation of the films 
The thickness of the blank films produced from pure 
polymers of PRO and CAR were 0.19 and 0.08 mm whereas 
their ART-loaded counterparts (PROART and CARART) were 
0.28 and 0.18 mm respectively. These values were within 
normal ranges reported for drug films in literature46. This 
shows that the PRO and/or PROART films were generally 
thicker than those of CAR and/or CARART.  
3.5. Bioadhesive evaluation of the films 
Bioadhesive determination revealed that work of adhesion 
varied depending on the polymer used. Table 1 generally 
shows that CARART films had higher work of adhesion (24 
g/mm) than PROART films (9 g/mm), similar to the pure 
polymers (CAR, 19 and PRO, 17 g/mm).  
3.6.  Thermogravimetric analysis (TGA) 
TGA result showed that water content within the films was 
dependent on the polymer used (Table 1).  Films produced 
from CAR and/or CARART had higher equilvalent water 
contents of 18 and 21 % respectively than those of PRO 
and/or PROART (10 and 15 %) respectively. The drug (ART) 
had a much lower equilibrium water content of 1.70 %, 
which agreed with an earlier study21.  
3.7. Differential scanning calorimetry (DSC) 
Enthalpy values of ART, CAR, PRO, CARART and PROART 
were 87.51, -3.16, -0.79, 76.02 and 21.63 J/g respectively 
(Table 1). This implies that the order of decreasing 
crystallinity was ART<CARART<PROART<CAR<PRO; 
implying that the polymer (PRO) and the film (PROART) 
were the least crystalline. In other words, PRO was the most 
amorphous and its drug film (PROART) was also more 
amorphous than CARART; which by extrapolation implied 
that it was a better system to entrap the very crystalline 
ART, than CAR.  
3.8. Infrared (FTIR) analysis 
To demonstrate that it was possible to incorporate ART into 
polymers, infrared spectra of free ART, ART-loaded films 
(CARART and PROART) were obtained alongside individual 
polymers and presented. The bands at 3772, 3294, 2970, 
2206, 1975, 1712, 1280, 1118 and 864 cm−1were due to the 
vibration of the functional groups (–OH, C-H, CH3, C=O and 
=C-H out of plane bending vibration of aromatics & enes) 
present in the structure of ART and can be seen in the 
spectra of the free ART, CARART, and PROART films. Spectra 
from films containing no ART did not show these peaks, 
indicating successful incorporation of ART into the buccal 
film formulations. Briefly, the band 3200-3400 cm-1 as seen 
in CAR, more pronounced than in PRO represent normal 
`polymeric` OH stretch, which can be broad stretching to 
3570-3200 cm-1 in PRO. The OH stretching vibration  (broad 
or not) were seen in the bands of 3400-3611 in CARAT; 
3570-3200 cm-1 in PROART and 3570-3200 cm-1 (H-bonded 
OH group) in PRO. Other prominent points of interaction 
were at 1900 cm-1 between CARART and ART due to 
aromaticity. PROART and ART had more prominent points of 
interaction at 2400, 1650-1590 (primary amine NH bend 
from PRO) and 1680-1620 cm-1 due to aromaticity (C=C)37.
 
 
Legends: 3200-3400 cm-1 as seen in CAR, more pronounced than in PRO represent normal `polymeric` OH stretch, it can be broad 
stretching to 3570-3200 cm-1 which is more pronounced in PRO. The OH stretching vibration  (broad or not) can been seen in the bands 
of 3400-3611 in CARAT, 3570-3200 cm-1 in PROART and 3570-3200 cm-1 (H-bonded OH group). Other prominent points of interaction 
are at 1900 cm-1 between CARART and ART due to aromaticity. PROART and ART have more prominent points of interaction at 2400, 
1650-1590 (primary amine NH bend from PRO) and 1680-1620 cm-1 due to aromaticity (C=C). 
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3.9. Dissolution studies 
The dissolution experiment utilized two different media: 
deionized water and simulated salivary fluid (pH 6.5). It was 
observed that in deionized water, ART release from CARART 
films was 6.8 % after 4 h whereas PROART released 11.8 % 
of ART at the same time; whereas in SSF, ART release from 
CARART films was 8.89 % and PROART was 16.18 % at the 
same time.  The high initial release of artemether observed in 
all the formulations may be caused by un-encapsulated drug 
and a little burst release of artemether at the periphery of 
drug films. This perhaps, may be due to the fact that ART-
loaded films of CARART and PROART generally had high 
particle sizes (2442 and 853 nm) respectively. Earlier works 
had highlighted that lower particle sizes increased drug 
release via increased surface area47-49. Therefore, since the 
drug films composed of high particle sizes, drug release was 
poor due to decreased surface area. More so, high 
polydispersity presents non-uniformity in release as 
different shapes and sizes of particles are involved.
 
 
Legend: Fast initial release was more pronounced in PROART than CARART but PROART release-curve was more sustained 
and preferrable with less undulation (n=3). 
 
Table 2: Kinetics of ART release from buccal films 
Drug Media Batches Zero order 
(R2) 
First order 
(R2) 
Higuchi 
(R2) 
Korsmeyer-Peppas 
Parameters (R2) 
 
ART 
Deionized 
water  
CARART 0.571 0.571 0.377 0.447 
PROART - - - - 
 Simulated 
salivary fluid 
(SSF) 
CARART 0.540 0.540 - 0.412 
PROART - - 0.377 - 
Legends: R2 values of the release models were generally low, perhaps due to complexity of the release whereas the theory of 
these kinetic models was based on simple defined release mechanisms and sometimes changing geometrics and structure of 
solid matrices. Hence, release of artemether could not be satisfactorily explained using the kinetic models 
 
3.10. Antiplasmodial activity of films 
The study showed a parasitemia reduction range of 146 – 
48, 150 – 36 and 131 – 21 for CARART, PROART and ART 
(commercial oral tablet) respectively (Fig. 5). Therefore, 
mean parasitemia reduction was 67, 76 and 84 % for 
CARART, PROART films and ART respectively (Fig. 6). These 
formulations had statistically significant (P < 0.05) 
antiplasmodial effects when compared to negative control 
group (S.D = 0.5) that received distilled water all through. 
The result equally confirmed that PROART had better 
antiplasmodial effect than CARART films, in agreement with 
all the earlier observations. 
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Legend: At day 1, the number of parasitized erythrocyte was nearly the same for all mice groups undergoing the treatment protocol. 
Subsequently at days 2-4, the number of parasitized erythrocyte continuously increased daily in the mice group that received 
deionized water. There was also a continuous pattern of decrease most prominently in ART (4.2), PROART (7.2) and CARART (9.6). The 
polymer (PRO and CAR) therefore, could serve as delivery carriers for artemether, as films for buccal use in malariogenic mice (n=3). 
 
Legend: As shown earlier the mice that received water continously increased in number of parasitized erythrocyte without any 
reduction. On the contrary, the drug (ART) and drug films (PROART and CARART) showed good percentage reduction of parasitaemi a 
respectively as 86, 76 and 67 %. Though ART tablet performed best, yet it was used as oral tablet without taste-masking whereas, drug 
films were sweetened with saccharine sodium and flavoured with mint oil, which could additionally improve acceptability (n=3).   
4. DISCUSSION 
In the past and present, many companies utilize oral and 
intramuscular drug delivery technologies to develop 
artemether. Recent advancement pries into the delivery of 
drugs through buccal film formulation; hence in this study, 
sublingual administration has been chosen as a delivery 
route for possible systemic delivery of artemether. 
Additionally, this approach is expected to improve patient 
compliance, since the extreme nausea-vomiting tendency of 
ART in the available conventional oral artemisinin 
combination therapies may be taken care of at once. The 
following results would provide proof as to hope for a 
sublingual ART regimen. 
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formulations (S.D ± 0.5) 
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The particle uniformity of PROART films showed better 
polydispersity index (0.6) than CARART (1.0) as well as the 
single polymers of CAR (0.8) and PRO (0.9). Zeta potential 
values for CAR (-50.5 mV) and CARART (-64 mV) were better 
than those of PRO (-9.6 mV) and PROART (-10 mV). This 
suggests that the films (loaded with ART or not) based on 
CAR would be more stable than those of PRO. More so, the 
CAR and/or CARART films were more transparent than the 
PRO and/or PROART ones; hence suggesting that the CAR 
and/or CARART films were more plastic and would most 
likely require more time for breaking the films than those of 
PRO and/or PROART. Subsequently, the folding endurance of 
the PROART film was 43 min whereas that of CARART film 
was 60 min. This confirms that CARART films were lighter 
(more plastic) with more uniform measurement than 
PROART films. Additionally, CARART films would adhere 
more at mucosal surface to dissolve and release ART faster 
than PROART films. This agreed with both observations in 
thickness and folding endurance implying that CARART films 
adhered longer to the chicken pouch as a model tissue 
surface, than the PROART films. Since buccal films generally 
need to be bio- and/or muco-adhesive to be able to 
withstand some obvious stresses due to their application 
sites, in order to provide both local and/or systemic effects, 
it therefore follows that the CARART films were better 
adapted for bio-/muco-adhesion than the PROART films. 
This suggests that the flushing action of saliva and/or food 
ingestion would not affect CARART films as much as the 
PROART films; even though both may suffer from frequent 
dosing, non-uniform absorption as well as dislodgement by 
the tongue10, 32. It was also observed that different films 
formulated with the same polymer had slight variation in 
water contents. Water molecules therefore, act as stabilizer 
to increase intermolecular spaces to allow polymeric chains 
to easily slide past each other50. This however affects 
stability, drug release and other physicochemical properties 
(elastic modulus) of the films formulated as would be 
established from the thermal analysis. 
DSC is a measurement tool that gives insight into the thermal 
properties of ingredients and formulations in terms of 
melting point, enthalpy and glass transition temperature18, 21, 
51. Summarily, high enthalpy values suggest high crystallinity 
of systems and vice versa. In other words, when a system has 
high enthalpy value, it is therefore rigid (crystalline) without 
enough space to entrap anything. This could also explain why 
the particle sizes of PRO and PROART films were in the 
nanoparticle subdivision rather than CARART; which by 
extension despite the low mucosal adhesivity of PROART 
films, could indicate that PROART films may have more 
sustained release of ART in SSF (pH 6.5) than CARART. 
Information obtained from FTIR measurement gives insight 
into the kind of interaction occurring due to the functional 
groups making up the systems. Fig. 3 shows the spectra of all 
measurements. The compatibility among the ART, polymers 
(CAR and PRO) and films (CARART and PROART) was 
studied. However, some new peaks were formed in both 
PROART (2083 cm−1) and CARART (3402, 2708, 2461, 2276, 
2036, 1813-1936, 1211 and 694 cm−1) due to intramolecular 
hydrogen bonding (O-H stretching vibration), aromatic, 
cyclic enes (υ=CH & Ar-H), akly groups (υCH3), C=O groups 
(υC=O) and aromatics & enes (=C-H out of plane bending 
vibration). These studies confirm that, structural 
components of polymers (CAR and PRO) responsible for 
their less crystallinity (according to DSC result) and perhaps 
dissolution enhancement may play vital role in establishing 
various interactions with drugs and consequently stabilize 
them thermodynamically. 
Many earlier reports carried out on stabilization using 
different polymers suggest the significance of hydrogen 
bonding in stabilization of amorphous valdecoxib using PVP 
and HPC52; comparative study of stabilization efficiency of 
Gelucire 50/13 and PVP and investigation of mechanism 
involved53; nanoporous silica xerogel, kaolin, and Mg–Al–
hydrocalcite involved in stabilization of amorphous 
nifedipine54, ibuprofen55, and celecoxib56 respectively. 
Polyvinyl pyrrolidone (PVP), hydroxypropyl cellulose (HPC), 
Gelucire and other carriers have been investigated to check 
their potential as stabilizer for amorphous form of drugs. 
PVP has been used to prevent devitrification of amorphous 
ketoconazole57. The mechanism of this stabilization is also 
traceable in the use of PRO and CAR to deliver ART as buccal 
films in this study. Alternatively, PRO has been proven to be 
a stabilizer for aceclofenac in addition to many other uses21. 
Release from CARART films followed a manner that was 
more controlled than PROART films, even though both 
release was poor (Figure not shown). On the other hand, ART 
release in SSF (pH 6.5) showed that CARART films achieved 
11.76 % release in 2 h whereas PROART released 16.82 % in 
2 h which was sustained till 10 h (Fig. 4). This suggests that 
for both fast and sustained release of ART, PROART films in 
SSF (pH 6.5) was the preferred formulation despite CARART 
films being more bioadhesive, stable (-64 mV), transparent 
(thinner) and more plastic. Meanwhile, ART (87.51 J/g) 
existed in more amorphous form in the PROART films (21.63 
J/g) than CARART films (76.02 J/g); which therefore proves 
the enhanced dissolution and release of ART obtained from 
PROART films. Subsequently, the fine particle subdivision 
(853 nm) and double thickness advantage (0.28 mm) of 
PROART films as compared to the size (2442 nm) and 
thickness (0.18 mm) of CARART particles/films, could 
explain the sustained release of ART till the 10th hour. 
However, the in vivo antiplasmodial activity would confirm 
these in vitro results. When the dissolution rate and pattern 
of the films were compared to the standard drug (pure ART), 
PROART in deionized water had dissolution pattern closer to 
it than CARART. The in vitro release was subjected to a 
kinetic analysis as shown in Table 2, for fitting into various 
models, such as zero-order, first-order, Higuchi, Hixson–
Crowell and Peppas exponential equation to ascertain the 
drug release. The plots were found linear, though release of 
ART from the films did not fit into any of the kinetic models. 
The plots generally had low R2 values. This behavior of the 
artemether films could be attributed to the complexity of the 
release, diffusion and permeation process, whereas the 
theory of these kinetic models was based on simple defined 
release mechanisms and sometimes changing geometrics 
and structure of solid matrices. Hence, release of artemether 
could not be satisfactorily explained using the kinetic 
models. 
The result of ex-vivo buccoadhesive strength for ART buccal 
films are shown in Table 1. Thus CARART films containing 
carrageenan polymer exhibited higher buccoadhesive 
strength (38) than PROART film (32) containing Prosopis 
africana polymer. This may be due to surface adhesion 
phenomenon as well as formation of secondary hydrogen 
bonds with mucosa as a result of rapid swelling of polymers 
involved. The single entities of the polymers (CAR and PRO) 
demonstrated similar trends as well. 
The therapeutic effect of CARART and PROART were tested 
on mice infected with Plasmodium beighei (NK 65). 
Reduction in parasite count was investigated by comparing 
mean parasiteamia pre- and post- treatment from the 
different film formulations. Mean parasitemia reduction was 
67, 76 and 84 % for CARART, PROART films and ART 
respectively. These formulations had statistically significant 
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(P < 0.05) antiplasmodial effects when compared to negative 
control group (S.D = 0.5) that received distilled water all 
through. The result equally confirmed that PROART had 
better antiplasmodial effect than CARART films, in 
agreement with all the earlier observations such as fine 
particle subdivision (853 nm), double thickness advantage 
(0.28 mm) and sustained in vitro release of ART. 
5. CONCLUSION 
This study has demonstrated that natural polymers (CAR and 
PRO) can conveniently deliver ART as buccal films to treat 
malariogenic mice. The characteristics of the drug films more 
desirably favoured PROART than CARART films; hence better 
drug dissolution, release and antiplasmodial activity due to 
more uniform (0.6) amorphous (21.63 J/g) nanoparticles 
(853 nm) make-up of PROART films which thickly (0.28 
mm), though porously and brittlely enclosed ART with lower 
equilibrium moisture content (15 %) for better stabilization 
(-10 mV) through intramolecular hydrogen bonding of the 
ART and PRO molecules; than CARART films with higher 
equilibrium water content (21 %) which increased 
intermolecular spaces allowing polymeric chains to easily 
slide past each other to expel entrapped ART. Overall, 
antiplasmodial efficacy was 86, 76 and 67 % corresponding 
to ART>PROART>CARART respectively. Since all 
formulations achieved reduction in parasitaemia between 67 
and 86 %, nonetheless, the improved ease of application and 
compliance, perhaps with elimination of vomiting and other 
gastrointestinal disturbances associated with conventional 
ART, could create hope for a clinical trial since 
antiplasmodial efficacy of the formulations were statistically 
significant. 
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